A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
NCT03896581
Arthritis, Arthritis, Psoriatic
Phoenix, Arizona, United States
View Trial DetailsNCT Number: NCT00580632
In Spain, there is little data available concerning the evolution and treatment of Psoriatic Arthritis by rheumatologists and dermatologists. This study is designed to obtain more data about the clinical and therapeutic management of Psoriatic Arthritis in Dermatology and Rheumatology Medical centers.
Looking for future studies?
Notify Me19 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: 12 months
Looking for future studies?
Notify MeWyeth is now a wholly owned subsidiary of Pfizer
Industry
Workload, Clinical and Therapeutic Management of Psoriatic Arthritis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03896581
Arthritis, Arthritis, Psoriatic
Phoenix, Arizona, United States
View Trial DetailsNCT04009499
Arthritis, Arthritis, Psoriatic
Phoenix, Arizona, United States
View Trial DetailsNCT06624228
Arthritis, Arthritis, Psoriatic
Gilbert, Arizona, United States
View Trial DetailsNCT07772687
Arthritis, Arthritis, Psoriatic
Bonn, North Rhine-Westphalia, Germany
View Trial Details